List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 38 studies with search of:   Japan | received on or after 11/14/2008
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
2 Not yet recruiting Paxil Japanese Post Marketing Paediatric Study in Depression (Double-Blind, Placebo Controlled Study)
Condition: Major Depressive Disorder
Interventions: Drug: paroxetine 20mg tablet;   Drug: matched placebo to paroxetine 20mg;   Drug: paroxetine 10mg tablet;   Drug: matched placebo to paroxetine 10mg
3 Recruiting Efficacy Confirmation Trial of CDP870 Without Coadministration of MTX in Japnese RA
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo of CDP870;   Drug: CDP870
4 Recruiting Long Term Administration Study of OPC-12759 Ophthalmic Suspension
Condition: Dry Eye Syndromes
Intervention: Drug: OPC-12759 Ophthalmic suspension
5 Not yet recruiting Clinical Evaluation of Ropinirole PR/XR Tablet for Adjunctive Therapy to L-Dopa in Subjects With Advanced Parkinson's Diseas
Condition: Parkinson's Disease
Interventions: Drug: ropinirole IR;   Drug: ropinirole PR/XR
6 Recruiting Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain
Conditions: Pain;   Analgesics
Intervention: Drug: Tapentadol
7 Recruiting ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients
Conditions: Osteoporosis;   Bone Loss, Age-Related
Intervention: Drug: YM529 / ONO-5920
8 Recruiting Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol 150 µg;   Drug: Indacaterol 300 µg;   Drug: Placebo
9 Not yet recruiting Inhaled Amikacin Solution (BAY41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Condition: Pneumonia
Interventions: Drug: Amikacin (BAY41-6551);   Drug: Aerosolized Placebo
10 Recruiting A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: RO4998452;   Drug: RO4998452;   Drug: RO4998452;   Drug: RO4998452;   Drug: RO4998452;   Drug: Placebo
11 Recruiting Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Placebo
12 Recruiting Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanse Patients With COPD
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: BI 1744 CL inhalation sulution
13 Recruiting A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Riociguat (BAY63-2521);   Drug: Placebo
14 Recruiting Novel Angioplasty Using Coronary Accessor
Condition: Radial Artery Occlusion
Intervention: Device: TRI using a 4-Fr guiding catheter
15 Recruiting Efficacy Confirmation Trial of CDP870 as Add-on Medication to MTX in Japanese RA
Condition: Rheumatoid Arthritis
Interventions: Drug: CDP870 400mg;   Drug: CDP870 200mg;   Drug: CDP870 100mg;   Drug: Placebo of CDP870
16 Recruiting A Phase I Clinical Trial to Assess the Safety of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Diffuse Large B-Cell Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma
Interventions: Drug: SyB L-0501;   Drug: Rituximab
17 Not yet recruiting Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-Cell Malignancies
Condition: Recurrent or Refractory T/NK-Cell Malignancies
Interventions: Drug: forodesine hydrochloride;   Drug: forodesine hydrochloride;   Drug: forodesine hydrochloride
18 Recruiting A Clinical Pharmacology and Exploratory Study of Decitabine Injection in Myelodysplastic Syndrome.
Condition: Myelodysplastic Syndrome
Intervention: Drug: Decitabine
19 Recruiting Randomized, db, Placebo-Controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Placebo
20 Recruiting Study Evaluating Single Doses of SBI-087 in Japanese Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: SBI-087

Previous Page Studies Shown (1-20) Next (21-38)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services